Vitalhub Corp. (TSE:VHI – Free Report) – Equities research analysts at Stifel Canada issued their Q3 2025 earnings per share estimates for Vitalhub in a report issued on Tuesday, October 14th. Stifel Canada analyst J. Keywood forecasts that the company will earn $0.03 per share for the quarter. Stifel Canada has a “Strong-Buy” rating on the stock. The consensus estimate for Vitalhub’s current full-year earnings is $0.23 per share. Stifel Canada also issued estimates for Vitalhub’s Q4 2025 earnings at $0.02 EPS, FY2025 earnings at $0.11 EPS, Q1 2026 earnings at $0.04 EPS, Q2 2026 earnings at $0.04 EPS, Q3 2026 earnings at $0.05 EPS, Q4 2026 earnings at $0.06 EPS and FY2026 earnings at $0.18 EPS.
Several other equities research analysts also recently issued reports on VHI. Stifel Nicolaus set a C$15.00 price target on Vitalhub and gave the stock a “buy” rating in a report on Wednesday. Raymond James Financial increased their price target on Vitalhub from C$14.50 to C$15.00 and gave the stock an “outperform” rating in a report on Tuesday, August 12th. TD Securities increased their price target on Vitalhub from C$15.00 to C$16.00 and gave the stock a “buy” rating in a report on Monday, August 11th. National Bankshares set a C$16.00 price target on Vitalhub and gave the stock an “outperform” rating in a report on Thursday, August 21st. Finally, Royal Bank Of Canada set a C$15.00 price target on Vitalhub and gave the stock a “moderate buy” rating in a report on Thursday, September 18th. Two investment analysts have rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of C$14.86.
Vitalhub Price Performance
Shares of Vitalhub stock opened at C$10.24 on Friday. Vitalhub has a 1 year low of C$8.50 and a 1 year high of C$14.64. The business has a 50-day moving average of C$11.76 and a two-hundred day moving average of C$11.34. The company has a market capitalization of C$643.38 million, a P/E ratio of 128.00, a price-to-earnings-growth ratio of 1.18 and a beta of 0.62.
Insider Activity
In other news, Director Steve Garrington sold 20,000 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the completion of the transaction, the director directly owned 60,000 shares of the company’s stock, valued at C$774,000. This represents a 25.00% decrease in their ownership of the stock. Also, Director Danny Matlow sold 150,000 shares of the company’s stock in a transaction dated Thursday, August 28th. The stock was sold at an average price of C$12.75, for a total value of C$1,912,500.00. Following the transaction, the director directly owned 520,001 shares of the company’s stock, valued at C$6,630,012.75. This represents a 22.39% decrease in their ownership of the stock. 18.57% of the stock is owned by corporate insiders.
About Vitalhub
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
See Also
- Five stocks we like better than Vitalhub
- What does consumer price index measure?
- This AI Chip Giant Could Be the Market’s Next Big Winner
- The Role Economic Reports Play in a Successful Investment Strategy
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.